Jack Hadfield: An Important Step Toward Finding Measurable Biology in Long COVID
Jack Hadfield, Co-founder and Research Lead at Amatica Health, shared a post on LinkedIn about a recent article by Asghar Abbasi et al, published in Infection:
”Pieces of SARS-CoV-2 proteins were found in tiny blood particles in people with long COVID, even many months after infection.
These particles are called extracellular vesicles, or EVs. EVs are small packages released by cells into the blood that can carry proteins and other biological material.
In this study, researchers looked at 14 adults with long COVID symptoms including fatigue, shortness of breath, exercise intolerance, and post-exertional malaise. On average, they were studied about 17 months after infection.
The team isolated EVs from blood samples and used mass spectrometry, a lab method that identifies molecules by their molecular pattern, to look for pieces of SARS-CoV-2 proteins.
They detected 65 viral protein fragments linked to a viral protein called Pp1ab in 22 of 56 samples. The authors also reported that each participant had at least one SARS-CoV-2 peptide detected in EVs at some point across the sampling period.
They then used a more targeted confirmation method and verified one specific viral peptide in 12 of the 14 participants across multiple time points. None of the 20 pre-pandemic control samples showed the same signal.
This does not prove live virus is still present. It does not prove these protein fragments are causing symptoms. And it does not establish a clinical test.
But it may point to an ongoing biological signal in at least some people with long COVID, and that is why this paper is worth paying attention to.
The main caveats are also important. This was a very small study. It was a short correspondence paper, not a large validation study. The signal was not found in every sample, and the study did not include a key comparison group of people who had COVID and recovered without long COVID.
So the balanced takeaway is this: early evidence, not proof, but a potentially important step toward finding measurable biology in long COVID.
The details above come directly from the paper’s cohort description, EV proteomics methods, peptide findings, targeted validation, and control comparisons”
Title: Possible long COVID biomarker: identification of SARS-CoV-2 related protein(s) in Serum Extracellular Vesicles
Authors: Asghar Abbasi, Ritin Sharma, Nathaniel Hansen, Patrick Pirrotte, William W. Stringer
Read the Full Article on Infection

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 17, 2026, 05:47Multidisciplinary Teams Kick Off SAHF MASAC ES 2026 with Pre-Symposium Workshops – South African Haemophilia Foundation
-
Nov 17, 2026, 05:41Boitumelo Malatji: South African Delegation Advances Advocacy Strategies at NNHF Southern Africa Workshop
-
Nov 17, 2026, 05:36Joining the PACTA Uganda Mental Health and Addiction Community Camp 2026 – Tackle Sickle Cell Africa
-
Nov 17, 2026, 05:30Nathan Connell: Women’s Hematology Summit 2027 to Address Hematologic Health Across the Lifespan
-
Nov 17, 2026, 05:25Mane Kurghinyan: Representing Armenia and HemAI Dynamics at the Falling Walls Lab Global Finale 2026
-
Nov 17, 2026, 01:27X. Long Zheng: Optimizing Treatment in Immune TTP
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH